
==== Front
Biophys Rep
Biophys Rep
swwlxb
Biophysics Reports
2364-3439
2364-3420
Biophysics Reports Editorial Office Beijing China

br-10-4-230
10.52601/bpr.2024.230030
Invited Review
Met1-linked ubiquitination in cell signaling regulation
Guo Yanmin 1*gmy631@163.com

Zhao Yuqin 1
Cong Yu-Sheng 1*yscong@hznu.edu.cn

1 Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University School of Basic Medical Sciences, Hangzhou 311121, China
gmy631@163.com (Y. Guo)
yscong@hznu.edu.cn (Y.-S. Cong)
31 8 2024
10 4 230240
30 10 2023
11 3 2024
© The Author(s) 2024
2024
The Author(s)
https://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Met1-linked ubiquitination (Met1-Ub), also known as linear ubiquitination, is a newly identified atypical type of polyubiquitination that is assembled via the N-terminal methionine (Met1) rather than an internal lysine (Lys) residue of ubiquitin. The linear ubiquitin chain assembly complex (LUBAC) composed of HOIP, HOIL-1L and SHARPIN is the sole E3 ubiquitin ligase that specifically generates Met1-linked ubiquitin chains. The physiological role of LUBAC-mediated Met1-Ub has been first described as activating NF-κB signaling through the Met1-Ub modification of NEMO. However, accumulating evidence shows that Met1-Ub is broadly involved in other cellular pathways including MAPK, Wnt/β-Catenin, PI3K/AKT and interferon signaling, and participates in various cellular processes including angiogenesis, protein quality control and autophagy, suggesting that Met1-Ub harbors a potent signaling capacity. Here, we review the formation and cellular functions of Met1-linked ubiquitin chains, with an emphasis on the recent advances in the cellular mechanisms by which Met1-Ub controls signaling transduction.

Ubiquitin
LUBAC
Met1-linked ubiquitination
Cell signaling
==== Body
pmcINTRODUCTION

Protein post-translational modifications (PTMs) refer to the covalent additions of functional groups or specific proteins to amino acids, which thereby extend the functional diversity and complexity of the proteome. To date, more than 450 types of PTMs have been identified (Venne et al. 2014). Among these, ubiquitination is one of the most widely studied PTMs, regulating nearly every aspect of cellular functions (Haglund and Dikic 2005). Among the eight types (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, Lys63 and Met1) of homogeneous polyubiquitin chains characterized, the Met1-Ub is the newly identified atypical type of polyubiquitination (Kirisako et al. 2006). The head-to-tail linear polyubiquitin chains have been originally considered as the translation product of UBB and UBC genes rather than the formation catalyzed by enzymes (Bianchi et al. 2015; Wiborg et al. 1985). Until 2006, Iwai and colleagues reported that LUBAC was a ubiquitin E3 ligase complex that possessed the feature to specifically assemble Met1-Ub (Kirisako et al. 2006). Later, Met1-Ub was demonstrated to activate the nuclear factor-κB (NF-κB) pathway (Tokunaga et al. 2009). Since then, Met1-Ub has attracted intense research attention to understand the mechanisms of its formation, regulation and biological functions. In this review, we describe the current insights into the conjugate and cleavage of Met1-linked ubiquitin chains with emphasis on the mechanisms of Met1-Ub in regulating cellular signal pathways.

THE MET1-UB SYSTEM

Met1-Ub is linked via the regular peptide bond between the C-terminal carboxyl group of one ubiquitin and the α-NH2 group of Met1 of another ubiquitin. This process requires three enzymes, ubiquitin-activating enzyme (E1), ubiquitin conjugating enzyme (E2) and ubiquitin ligase (E3), among which E3s determine the specificity of ubiquitin linkage and substrate. To date, LUBAC is proven to be the only known E3 ubiquitin ligase capable of assembling Met1-Ub. OTU deubiquitinase with linear linkage specificity (OTULIN; also known as FAM105B or Gumby) and cylindromatosis (CYLD) are the DUBs to specifically disassemble these ubiquitin chains.

Unique features of E3 ligase complex LUBAC

In 2006, Kazuhiro Iwai’s team identified a novel E3 complex with a size of ~600 kDa and found that haem-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L; also known as RBCK1) and HOIL1-interacting protein (HOIP; also known as RNF31) were the two crucial proteins for this complex formation. This E3 complex could specifically assemble N-terminal Met1-linked ubiquitin chains rather than Lys-linked types in conjunction with several E2s, such as E2-25K, UbcH5s and UbcH7. Considering the nature of this complex, they named it the linear ubiquitin chain assembly complex (LUBAC). In 2011, three research groups observed that SHANK-associated RH domain-interacting protein (SHARPIN; also known as SIPL1) was a novel subunit of LUBAC (Gerlach et al. 2011; Ikeda et al. 2011; Tokunaga et al. 2011). Thus, LUBAC is considered a ternary complex composed of HOIP, HOIL-1L and SHARPIN (Fig. 1A).

Figure 1 Met1-Ub system. A Schematic diagram of the LUBAC subunits, HOIP, HOIL-1L and SHARPIN. Arrows indicate interactions. B The model that LUBAC conjugates Met1-Ub to the substrate. E1 activates ubiquitin and leads to the formation of a thioester bond between the C terminus of ubiquitin and the catalytic cysteine of E1 (E1~Ub). Then the activated ubiquitin is transferred to the catalytic cysteine of E2 to form the E2~Ub thioester intermediate. Concomitantly, LUBAC binds E2~Ub and substrate to facilitate the transfer of ubiquitin molecules to the substrate. Arrows indicate the transfer of ubiquitin molecular. C Schematic diagram of LUBAC-associated DUBs, OTULIN and CYLD-SPATA2. Arrows indicate interactions. PUB, peptide:N-glycanase/ubiquitin-associated UBA-containing or UBX-containing protein; ZF, zinc finger; NZF, Npl4-like zinc finger; UBA, ubiquitin-associated; RING, really interesting new gene; IBR, in-between-RING; LDD, linear ubiquitin chain-determining domain; PH, pleckstrin homology; LTM, LUBAC-tethering motif; UBL, ubiquitin-like; PIM, PUB-interacting motif; OTU, ovarian tumour; CAP-Gly, cytoskeleton-associated protein glycine-rich; USP, Ubiquitin specific protease; B-box, B-box type zinc finger

HOIP is the catalytically active subunit of LUBAC. The C-terminal RING1-IBR-RING2 (RBR) domain directly assembles Met1-Ub and is the enzymatically active catalytic domain. The linear ubiquitin chain-determining domain (LDD) is unique for HOIP and determines the specific formation of the Met1 linkage. However, when HOIP exists alone, it appears to exert little E3 activity due to the autoinhibited conformation by the intramolecular interaction between RBR and ubiquitin-associated (UBA) domains. The ubiquitin-like (UBL) domains of HOIL-1L and SHARPIN interact with the UBA domain of HOIP to release HOIP autoinhibition, contributing to full HOIP E3 ligase activity (Fujita et al. 2018; Tokunaga et al. 2009, 2011). In addition, LUBAC-tethering motifs (LTMs) in HOIL-1L and SHARPIN associate with each other to form a globular domain that is crucial in maintaining the stability of LUBAC (Fujita et al. 2018).

The assembly of Met1-Ub

Like Lys-linked polyubiquitin chains, Met1-Ub also occurs through a sequential cascade of E1, E2 and E3. In the presence of Mg2+ and ATP, E1 activates a donor ubiquitin and transfers it to E2 to form E2~Ub thioester intermediate. Then RING1 domain of HOIP interacts with E2~Ub and transfers ubiquitin to the Cys885 site of its RING2 domain, forming an HOIP~Ub intermediate. Concomitantly, the C-terminal carboxyl group (-COOH) of donor ubiquitin is attached to the α-NH2 group of Met1 of acceptor ubiquitin, forming Met1-linked ubiquitin chains (Fig. 1B). The conserved RING2 has a role in positioning the acceptor ubiquitin and works with the LDD domain to lock the acceptor ubiquitin so that the α-NH2 of Met1 is the only one in proximity for the attack by donor ubiquitin rather than the ε-NH2 of any one of the seven lysine residues (Lechtenberg et al. 2016; Stieglitz et al. 2013).

Typically, ubiquitination occurs on the Lys residues of the substrate. Since HOIP targets the Met1 for ubiquitin conjugation, whether the Lys-linked ubiquitin on substrates is directly attached by HOIP remains controversial. It has been proposed that HOIP generates Met1-Ub using pre-existing Lys63-Ub as the acceptor, giving rise to hybrid Lys63/Met1-Ub chains (Emmerich et al. 2013, 2016). However, the E3(s) for the generation of pre-existing Lys63-Ub is not yet known. Recent studies have showed that HOIL-1L possesses the ability to conjugate monoubiquitin onto all LUBAC components, which is conducive to the formation of Met1-Ub mediated by HOIP (Fuseya et al. 2020), and HOIL-1L is responsible for the initiation of Met1-Ub by attaching first ubiquitin to the Lys residue of NEMO, a known substrate of LUBAC, and then HOIP is for the following Met1-Ub chain elongation (Smit et al. 2013). These suggest that HOIL-1L may play a key role in mediating the conjugation of ubiquitin onto the Lys residue of LUBAC’s substrates. Whether HOIL-1L or other E3 ligases are responsible for the initiation of Met1-Ub by attaching first ubiquitin to the Lys residue of substrates remains to be studied.

The disassembly of Met1-Ub

The Met1-Ub system is tightly controlled by DUBs. Two DUBs have been reported to effectively hydrolyze Met1-Ub. They are OTULIN and CYLD (Fig. 1C). OTULIN belongs to the ovarian tumor (OTU) family of DUBs and is the only known DUB that exclusively disassembles Met1-Ub. Crystal structure reveals this specificity is due to a high affinity between the OTU domain of OTULIN and Met1 linkage, and a mechanism named “substrate-assisted catalysis” in which Glu16 residue on the proximal ubiquitin directly participates in the formation of the active site and activates OTULIN (Keusekotten et al. 2013). Besides the OUT catalytic domain, OTULIN contains a conserved PIM motif through which OTULIN is recruited to LUBAC by binding to HOIP PUB domain to antagonize LUBAC-mediated Met1-Ub (Schaeffer et al. 2014).

CYLD belongs to the ubiquitin specific protease (USP) family of DUBs and cleaves both Met1-Ub and Lys63-Ub. Since the structure of Met1-Ub is the most similar to that of Lys63-Ub among the eight types of ubiquitin chains, CYLD associates with and disassembles Met1-Ub and Lys63-Ub in a similar manner (Komander et al. 2009). In addition, CYLD also associates with HOIP. However, their interaction is indirect and requires the spermatogenesis-associated 2 (SPATA2) to act as the adaptor protein. The PIM motif and the PUB domain of SPATA2 binds to the PUB domain of HOIP and the USP domain of CYLD, respectively, which contributes to the formation of LUBAC-SPATA2-CYLD complex (Elliott et al. 2016).

CELLULAR FUNCTIONS OF MET1-UB

Met1-Ub exerts its cellular roles largely by modifying substrates to affect protein activity, interaction, stability and subcellular localization (Table 1). So far, Met1-Ub has been demonstrated to be involved in some biological processes including NF-κB, mitogen-activated protein kinases (MAPK), Wnt/β-Catenin, the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), interferon (IFN) signaling, angiogenesis, mRNA homeostasis, protein quality control and so on (Fig. 2).

Table 1 The substrates of LUBAC

Substrate	Function of Met1-Ub	Reference	
NEMO	Facilitating IKK activation	Tokunaga et al. (2009)	
LUBAC	Destabilizing LUBAC components and impairing its ability	Keusekotten et al. (2013),
Heger et al. (2018)	
TRIM25	InducingTRIM25 degradation and inhibiting TRIM25 interaction with RIG-I.	Inn et al. (2011)	
RIPK1	Promoting the recruitment of A20 to the TNF-RSC	Gerlach et al. (2011),
Draber et al. (2015)	
RIPK2	Promoting the recruitment of NEMO to facilitate IKK activation	Fiil et al. (2013)	
TNFR	Promoting the recruitment of A20 to the TNF-RSC	Draber et al. (2015)	
TRADD	Promoting the recruitment of A20 to the TNF-RSC	Draber et al. (2015)	
IRAK1	Activating the canonical IKK complex	Emmerich et al. (2013)	
IRAK4	Activating the canonical IKK complex	Emmerich et al. (2013)	
MyD88	Activating the canonical IKK complex	Emmerich et al. (2013)	
ASC	Regulating NLRP3 inflammasome activation	Rodgers et al. (2014)	
FADD	Unknown (may affect cell survival and death.)	Goto and Tokunaga (2017)	
Caspase-8	Unknown (may directly or indirectly inhibit caspase-8 activity)	Lafont et al. (2017)	
ATG13	Stabilizing ATG13 protein and activating autophagy.	Chu et al. (2021)	
cFLIP	Stabilizing cFLIP and protecting cells from TNFα-induced apoptosis	Tang et al. (2018)	
PKC	Promoting degradation of activated PKC	Nakamura et al. (2006)	
BCL10	Required for the association of BCL10 with NEMO and NF-κB activation	Yang et al. (2016)	
STAT1	Inhibiting STAT1 binding to IFNAR2 and restricting STAT1 activation	Zuo et al. (2020)	
STAT3	Inhibiting STAT3 activity by recruitment of the phosphatase TC-PTP to STAT3	Du et al. (2023)	
Htt-polyQ	Promoting Htt-polyQ degradation and decreasing proteotoxicity	van Well et al. (2019)	
Ago2	Restraining miRNA-mediated gene silencing	Zhang et al. (2021)	
ALK1	Inhibiting ALK1 enzyme activity and Smad1/5 activation	Fu et al. (2021)	
PTEN	Inhibiting PTEN phosphatase activity and promoting prostate cancer progression	Guo et al. (2022)	
LKB1	Promoting LKB1 activity and AMPK activation	Chen et al. (2023)	
GPX4	Stabilizing GPX4	Dong et al. (2022)	
CENP-E	Facilitating the anchoring of CENP-E by KNL1 at attached kinetochores to promote chromosome congression and alignment

	Wu et al. (2019)	
HIF1α	Stabilizing HIF1α protein and promoting angiogenesis and lung tumorigenesis	Jin et al. (2024)	

Figure 2 Functions of Met1-Ub in cell signaling. Various upstream stimuli lead to multiple regulation events that activate LUBAC. Then, LUBAC conjugates Met1-Ub on downstream substrates that are involved in the regulation of diverse cellular functions. The cell signaling regulated by Met1-Ub and a partial list of known substrates is shown at the bottom

NF-κB signaling

Met1-Ub has been extensively studied in activating NF-κB signaling in response to tumor necrosis factor (TNF). Upon TNFα stimulation, TNF receptor (TNFR) recruits TNFRSF1A associated via death domain (TRADD), TNF receptor associated factor 2 (TRAF2), receptor-interacting protein kinase 1 (RIPK1) and cellular inhibitor of apoptosis protein 1/2 (cIAP1/2) to form TNF receptor signaling complex (TNF-RSC; named complex-I). Within this complex, the E3 ligase cIAP1/2 conjugates the Lys63-Ub on RIPK1 or other substrates. Subsequently, LUBAC is recruited to TNF-RSC by recognizing the Lys63-Ub through the NZF domains of HOIP and SHARPIN, and conjugates Met1-Ub on RIPK1, TRADD, TNFR and itself. The Lys63-Ub and Met1-Ub assembled by cIAP1/2 and LUBAC serve as the adaptors for the next recruitment of two kinase complexes, the transforming growth factor-β (TGF-β)-activated kinase 1/TAK1-binding proteins (TAK1/TAB) and IKK, respectively. The recruitment of IKK results in the Met1-Ub of NEMO by LUBAC and phosphorylation of IKKβ by TAK1/TAB, which promotes IKK activation (Zhang et al. 2014). In turn, IKK phosphorylates IκBα, leading to its degradation by the proteasome. Thus, free NF-κB are released from IκBα and translocate into the nucleus where they drive transcription of multiple responsive genes (Fig. 3). Once any one of the LUBAC components is absent, the Met1-Ub level of RIPK1 will decrease, which may cause the dissociation of RIPK1 from complex-I, leading to the destabilization of complex-I and the formation of complex-II (Gerlach et al. 2011; Haas et al. 2009; Ikeda et al. 2011; Tokunaga et al. 2011). In response to TNF, complex-II can induce cell death through apoptosis or necroptosis (Fig. 3). Therefore, LUBAC-mediated Met1-Ub is crucial for maintaining NF-κB signaling through activating IKK and stabilizing complex-I.

Figure 3 Met1-Ub plays a central role in TNF-induced NF-кB signaling and cell death. TNF stimulation triggers the recruitment of LUBAC to complex-I where it mediates the Met1-Ub of NEMO and other components of TNF-RSC. Met1-Ub of NEMO activates IKK and subsequent NF-кB signaling. Met1-Ub of the components of TNF-RSC prevents the formation of complex-II, thereby suppressing TNF-induced cell death, apoptosis and necroptosis. DUBs such as OTULIN and CYLD antagonize the actions of LUBAC by restricting the accumulation of Met1-Ub. LUBAC recruitment also ensures the full activation of the MAPK pathway. Different ubiquitin linkage types are indicated in the figure

LUBAC-associated DUBs can negatively regulate NF-κB signaling by inhibiting Met1-Ub (Verboom et al. 2021). OTULIN removes the Met1-Ub from TFNR-RSC, such as RIPK1 and NEMO, counteracting Met1-Ub-mediated NF-κB signaling (Fiil et al. 2013; Keusekotten et al. 2013). CYLD can remove both Lys63-Ub and Met1-Ub from RIPK1 and NEMO, and thereby suppressing the activation of the NF-κB (Draber et al. 2015). A20 (also known as TNFAIP3) suppresses Met1-Ub-mediated NF-κB activation by disrupting the binding of NEMO to LUBAC via interacting with the Met1-Ub utilizing its ZF7 domain (Tokunaga et al. 2012). Furthermore, PTMs can fine-tune the functions of HOIP to control LUBAC-mediated NF-κB signaling. Phosphorylation of HOIP at Ser1066 in the LDD region by MST1 attenuates LUBAC E3 ligase activity and negatively regulates the NF-κB-dependent inflammatory gene expression induced by TNFα (Lee et al. 2019). Ubiquitination of the HOIP Lys1056 site causes a conformational change of HOIP to block LUBAC activity and ultimately terminate LUBAC-mediated NF-κB signaling (Bowman et al. 2015).

In addition to TNFR, LUBAC-mediated Met1-Ub is also involved in NF-κB signaling triggered by interleukin 1 receptors (IL-1Rs) (Tokunaga et al. 2009), nucleotide-binding oligomerisation domain 2 (NOD2) (Damgaard et al. 2012), Toll-like receptors (TLRs) (Zinngrebe et al. 2016), cluster of differentiation 40 (CD40) (Ikeda et al. 2011), T cell receptors (TCRs) (Yang et al. 2016), epidermal growth factor receptor (EGFR) (Hua et al. 2021) and DNA damage (Niu et al. 2011). Although the stimuli and receptors vary, signaling cascades share a similar architecture as follows: (1) the formation of receptor signaling complexes (RSCs); (2) the recruitment of LUBAC to RSCs; (3) LUBAC-mediated Met1-Ub of NEMO and other complements of RSCs; (4) IKK and subsequent NF-κB activation.

MAPK signaling

In response to TNF stimuli, LUBAC enhances the stabilization of TNF-RSC and subsequent TAK1 activation that mediates not only the NF-κB signaling but also the MAPK cascades. Depletion of any of the LUBAC components has been shown to reduce the activation of MAPK signaling in response to inflammatory cytokines in different cell lines, indicating that Met1-Ub is necessary for the activation of MAPK signaling (Chen et al. 2019; Haas et al. 2009). However, some studies have reported that the activation of the c-Jun aminoterminal kinase (JNK) and ERK is unchanged, even slightly enhanced, in the absence of either HOIL-1L or SHARPIN (Tokunaga et al. 2009, 2011). Importantly, MEF cells from knockin mice expressing HOIPC879S (the inactive mutant) show unchanged activation of JNK and p38 MAPK signaling in response to IL-1α (Zhang et al. 2014), appearing that HOIP E3 activity is dispensable for MAPK activation. Thus, the roles of Met1-Ub in MAPK signaling are still controversial and the underlying mechanism by which Met1-Ub regulates MAPK signaling requires further studies.

Wnt/β-Catenin signaling

Studies have shown that Wnt/β-Catenin signaling may be negatively regulated by LUBAC and positively regulated by OTULIN, emphasizing that the balance of the Met1-Ub system is critical for maintaining Wnt/β-Catenin signaling. HOIP knockdown in adrenocortical carcinoma cells is shown to affect the Wnt pathway target gene expression (Ehrlund et al. 2012). Notably, homozygous mutant mice carrying the loss-of-function mutations in OTULIN (W96R and D336E) are embryonically lethal due to the defective Wnt/β-Catenin signaling and angiogenesis, characterized by the accumulation of Met1-Ub (Rivkin et al. 2013). OTULIN interacts with disheveled 2 (DVL2) to promote Wnt signaling and binds to the HOIP to antagonize LUBAC-mediated inhibition of Wnt signaling (Rivkin et al. 2013; Takiuchi et al. 2014). Moreover, OTULIN phosphorylation at Tyr56 by the tyrosine protein kinase ABL1 enhances its interaction with β-catenin while diminishing its association with HOIP, which inhibits β-catenin Met1-Ub and its degradation to promote Wnt/β-Catenin activation (Wang et al. 2020).

PI3K/AKT signaling

The indication that Met1-Ub is involved in PI3K/AKT signaling comes from the observations that HOIP and SHARPIN interact with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) to reduce PTEN function to potentiate PI3K/AKT signaling (De Melo et al. 2014a, b; Niu et al. 2021). The direct evidence for Met1-Ub regulating PI3K/AKT signaling is derived from the identification that PTEN is directly modified by Met1-Ub (Guo et al. 2022). Mechanistically, LUBAC (HOIP+SHARPIN) conjugates Met1-Ub chains to PTEN, which significantly inhibits PTEN phosphatase activity and accelerates the activation of PI3K/AKT signaling, promoting prostate cancer progression (Guo et al. 2022). Thus, LUBAC-mediated Met1-Ub is a critical signal mediator in PI3K/AKT activation and tumor progression.

Interferon (IFN) signaling

Met1-Ub shows an important role in antiviral responses through suppressing IFN signaling. One study found that Met1-Ub chains were conjugated on the tripartite motif-containing protein 25 (TRIM25) to induce TRIM25 degradation and inhibit its interaction with retinoic acid-inducible gene I (RIG-1), thereby negatively regulating RIG-I-mediated type I IFN induction (Inn et al. 2011). Another study suggested that Met1-Ub of NEMO competed with the mitochondrial antiviral signaling protein (MAVS) to bind TNF receptor-associated factor 3 (TRAF3), disrupting the interferon regulatory factor 3 (IRF3) signaling cascade and reducing IFN production (Belgnaoui et al. 2012). Moreover, Met1-Ub was reported to restrict the signal transducer and activator of transcription 1 (STAT1) activation, thereby inhibiting antiviral IFN signaling (Zuo et al. 2020).

The emerging functions of Met1-Ub

Recent work has revealed that Met1-Ub also has other cellular functions besides the above mentioned. The role of Met1-Ub in regulating angiogenesis is illustrated in mouse models, in which mice harboring OTULIN mutant or deficiency are embryonic lethal due to angiogenesis defects (Fu et al. 2021; Rivkin et al. 2013). The possible mechanism is that LUBAC mediated the Met1-Ub of the activin receptor-like kinase 1 (ALK1) to inhibit ALK1 enzyme activity and Smad1/5 activation, leading to the abnormal expression of downstream target genes that mediate vasculature and angiogenesis (Fu et al. 2021). Conversely, OTULIN deubiquitinates ALK1 to promote its activation, thus governing angiogenesis (Fu et al. 2021). Notably, studies reveal that Met1-Ub can act as a degradation signal to control protein quality (van Well et al. 2019), although previous studies suggest that Met1-Ub more inclines to be a cellular transduction signal. LUBAC promotes TRIM25 Met1-Ub and induces its proteasomal degradation, suppressing IFN-mediated antiviral signaling (Inn et al. 2011). Further, HOIP is reported to be recruited to the misfolded Huntingtin with an expanded polyglutamine tract (Htt-polyQ) in a p97/VCP-dependent manner, promoting Met1-Ub of Htt-Q97 and subsequent degradation, and decreasing proteotoxicity (van Well et al. 2019). And LUBAC itself also undergoes Met1-Ub-mediated proteasomal degradation. Increased auto-Met1-Ub and subsequent degradation of LUBAC have been reported in some OTULIN-deficient cells (Damgaard et al. 2019; Heger et al. 2018). In addition, Met1-Ub is also involved in autophagy. Study shows that Met1-Ub promotes autophagy initiation and maturation by controlling the Met1-Ub of autophagy-related protein 13 (ATG13) (Chu et al. 2021). Recently, Met1-Ub has been demonstrated to control chromosome alignment during mitosis (Wu et al. 2019). LUBAC targets the kinetochore motor CENP-E for Met1-Ub, which promotes the recruitment of CENP-E by KNL1, a newly identified receptor for Met1-Ub, to facilitate chromosome congression and dynamic chromosome alignment. Although Met1-Ub has been reported to be involved in diverse cellular processes (Fig. 2), the physiological functions and precise mechanisms merit a future investigation.

SUMMARY AND PERSPECTIVES

During the past dozen years, many advances have been made in understanding of the principle for formation and disassembly of Met1-Ub. The LUBAC/DUBs act as the on/off switch in controlling the Met1-Ub system, thereby regulating protein function and allowing for a rapid response to stimuli. Undoubtedly, strict regulation of LUBAC and its associated DUBs is critical for normal Met1-Ub functions. However, there are few researches to study how the activity and function of LUBAC are regulated. In addition, it is evident that the recruitment of LUBAC is conducted differently depending on variable stimuli, how it is specifically recruited to cellular locations requires further investigation.

Met1-Ub was originally identified to activate NF-κB signaling to regulate inflammation and immunity responses and it has since been found to regulate other signaling pathways and physiologic processes (see the previous section). Given that Met1-Ub exerts diverse biological functions mainly through modifying target proteins, exploring new substrates for Met1-Ub is necessary to better understand its cellular function and mechanism. In mice, a deficiency of HOIP causes embryonic lethality (Peltzer et al. 2014), and SHARPIN deficient mice exhibit severe chronic proliferative dermatitis (Seymour et al. 2007). In human, aberrance of Met1-Ub cascade is implicated in a variety of diseases, including cancer (Jimbo et al. 2023; Yang et al. 2014), autoinflammation (Boisson et al. 2015), immunodeficiency (Boisson et al. 2015; Oda et al. 2019), amylopectinosis (Boisson et al. 2012), polyglucosan storage myopathy (Nilsson et al. 2013) and Alzheimer's disease (Asanomi et al. 2022). These results imply that the LUBAC activity is required for the maintenance of normal physiology. Many LUBAC inhibitors have been identified and reported to effectively suppress Met1-Ub and regulate cell signaling (Fujita et al. 2018; Hua et al. 2021; Katsuya et al. 2019), suggesting new strategies for diagnosis and therapeutic intervention in diseases by targeting Met1-Ub.

Conflict of interest

Yanmin Guo, Yuqin Zhao and Yu-Sheng Cong declare that they have no conflict of interest.

Compliance with Ethical Standards

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.
==== Refs
References

Asanomi Y, Shigemizu D, Akiyama S, Miyashita A, Mitsumori R, Hara N, Ikeuchi T, Niida S, Ozaki K A functional variant of SHARPIN confers increased risk of late-onset Alzheimer's disease J Hum Genet 2022 67 4 203 208 10.1038/s10038-021-00987-x 34737388
Belgnaoui SM, Paz S, Samuel S, Goulet ML, Sun Q, Kikkert M, Iwai K, Dikic I, Hiscott J, Lin R Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex Cell Host Microbe 2012 12 2 211 222 10.1016/j.chom.2012.06.009 22901541
Bianchi M, Giacomini E, Crinelli R, Radici L, Carloni E, Magnani M Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple transcript variants Gene 2015 573 1 100 109 10.1016/j.gene.2015.07.030 26172870
Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, Lidov HG, Hopkins G, Du L, Belkadi A, Chrabieh M, Itan Y, Picard C, Fournet JC, Eibel H, Tsitsikov E, Pai SY, Abel L, Al-Herz W, Casanova JL, Israel A, Notarangelo LD Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia J Exp Med 2015 212 6 939 951 10.1084/jem.20141130 26008899
Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israel L, Trevejo-Nunez G, Bogunovic D, Cepika AM, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debre M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet JC, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Israel A, Casanova JL, Picard C Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency Nat Immunol 2012 13 12 1178 1186 10.1038/ni.2457 23104095
Bowman J, Rodgers MA, Shi MD, Amatya R, Hostager B, Iwai K, Gao SJ, Jung JU Posttranslational modification of HOIP blocks toll-like receptor 4-mediated linear-ubiquitin-chain formation mBio 2015 6 6 e01777 15 10.1128/mBio.01777-15 26578682
Chen B, Zheng Y, Zhu JN, Liang YH SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-kappa B pathway in mycosis fungoides Exp Dermatol 2019 28 11 1279 1288 10.1111/exd.14026 31461795
Chen Y, Liu Y, Jiang K, Wen Z, Cao X, Wu S Linear ubiquitination of LKB1 activates AMPK pathway to inhibit NLRP3 inflammasome response and reduce chondrocyte pyroptosis in osteoarthritis J Orthop Translat 2023 39 1 11 10.1016/j.jot.2022.11.002 36514784
Chu Y, Kang Y, Yan C, Yang C, Zhang T, Huo H, Liu Y LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13 Autophagy 2021 17 7 1684 1699 10.1080/15548627.2020.1781393 32543267
Damgaard RB, Elliott PR, Swatek KN, Maher ER, Stepensky P, Elpeleg O, Komander D, Berkun Y OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death EMBO Mol Med 2019 11 3 e9324 10.15252/emmm.201809324 30804083
Damgaard RB, Nachbur U, Yabal M, Wong WWL, Fiil BK, Kastirr M, Rieser E, Rickard JA, Bankovacki A, Peschel C, Ruland J, Bekker-Jensen S, Mailand N, Kaufmann T, Strasser A, Walczak H, Silke J, Jost PJ, Gyrd-Hansen M The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity Mol Cell 2012 46 6 746 758 10.1016/j.molcel.2012.04.014 22607974
De Melo J, Lin X, He L, Wei F, Major P, Tang D SIPL1-facilitated PTEN ubiquitination contributes to its association with PTEN Cell Signal 2014a 26 12 2749 2756 10.1016/j.cellsig.2014.08.013 25152374
De Melo J, Wu V, He L, Yan J, Tang D SIPL1 enhances the proliferation, attachment, and migration of CHO cells by inhibiting PTEN function Int J Mol Med 2014b 34 3 835 841 10.3892/ijmm.2014.1840 25018115
Dong K, Wei R, Jin T, Zhang M, Shen J, Xiang H, Shan B, Yuan J, Li Y HOIP modulates the stability of GPx4 by linear ubiquitination Proc Natl Acad Sci USA 2022 119 44 e2214227119 10.1073/pnas.2214227119 36279464
Draber P, Kupka S, Reichert M, Draberova H, Lafont E, de Miguel D, Spilgies L, Surinova S, Taraborrelli L, Hartwig T, Rieser E, Martino L, Rittinger K, Walczak H LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes Cell Rep 2015 13 10 2258 2272 10.1016/j.celrep.2015.11.009 26670046
Du X, Pang J, Gu B, Si T, Chang Y, Li T, Wu M, Wang Z, Wang Y, Feng J, Wu N, Man J, Li H, Li A, Zhang T, Wang B, Duan X A bio-orthogonal linear ubiquitin probe identifies STAT3 as a direct substrate of OTULIN in glioblastoma Nucleic Acids Res 2023 51 3 1050 1066 10.1093/nar/gkad002 36660824
Ehrlund A, Jonsson P, Vedin LL, Williams C, Gustafsson JA, Treuter E Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFbeta, and Wnt/beta-catenin signaling in adrenocortical carcinoma cells PLoS One 2012 7 3 e32080 10.1371/journal.pone.0032080 22427816
Elliott PR, Leske D, Hrdinka M, Bagola K, Fiil BK, McLaughlin SH, Wagstaff J, Volkmar N, Christianson JC, Kessler BM, Freund SMV, Komander D, Gyrd-Hansen M SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling Mol Cell 2016 63 6 990 1005 10.1016/j.molcel.2016.08.001 27591049
Emmerich CH, Bakshi S, Kelsall IR, Ortiz-Guerrero J, Shpiro N, Cohen P Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling Biochem Biophys Res Commun 2016 474 3 452 461 10.1016/j.bbrc.2016.04.141 27133719
Emmerich CH, Ordureau A, Strickson S, Arthur JS, Pedrioli PG, Komander D, Cohen P Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains Proc Natl Acad Sci USA 2013 110 38 15247 15252 10.1073/pnas.1314715110 23986494
Fiil BK, Damgaard RB, Wagner SA, Keusekotten K, Fritsch M, Bekker-Jensen S, Mailand N, Choudhary C, Komander D, Gyrd-Hansen M OTULIN restricts Met1-linked ubiquitination to control innate immune signaling Mol Cell 2013 50 6 818 830 10.1016/j.molcel.2013.06.004 23806334
Fu Y, Wang H, Dai H, Zhu Q, Cui CP, Sun X, Li Y, Deng Z, Zhou X, Ge Y, Peng Z, Yuan C, Wu B, Yang X, Li R, Liu CH, He F, Wei W, Zhang L OTULIN allies with LUBAC to govern angiogenesis by editing ALK1 linear polyubiquitin Mol Cell 2021 81 15 3187 3204 10.1016/j.molcel.2021.05.031 34157307
Fujita H, Tokunaga A, Shimizu S, Whiting AL, Aguilar-Alonso F, Takagi K, Walinda E, Sasaki Y, Shimokawa T, Mizushima T, Ohki I, Ariyoshi M, Tochio H, Bernal F, Shirakawa M, Iwai K Cooperative domain formation by homologous motifs in HOIL-1L and SHARPIN plays a crucial role in LUBAC stabilization Cell Rep 2018 23 4 1192 1204 10.1016/j.celrep.2018.03.112 29694895
Fuseya Y, Fujita H, Kim M, Ohtake F, Nishide A, Sasaki K, Saeki Y, Tanaka K, Takahashi R, Iwai K The HOIL-1L ligase modulates immune signalling and cell death via monoubiquitination of LUBAC Nat Cell Biol 2020 22 6 663 673 10.1038/s41556-020-0517-9 32393887
Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW, Nachbur U, Gangoda L, Warnken U, Purcell AW, Silke J, Walczak H Linear ubiquitination prevents inflammation and regulates immune signalling Nature 2011 471 7340 591 596 10.1038/nature09816 21455173
Goto E, Tokunaga F Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP Biochem Biophys Res Commun 2017 485 1 152 159 10.1016/j.bbrc.2017.02.040 28189684
Guo Y, He J, Zhang H, Chen R, Li L, Liu X, Huang C, Qiang Z, Zhou Z, Wang Y, Huang J, Zhao X, Zheng J, Chen GQ, Yu J Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression Oncogene 2022 41 44 4877 4892 10.1038/s41388-022-02485-6 36192478
Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, Koschny R, Komander D, Silke J, Walczak H Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction Mol Cell 2009 36 5 831 844 10.1016/j.molcel.2009.10.013 20005846
Haglund K, Dikic I Ubiquitylation and cell signaling EMBO J 2005 24 19 3353 3359 10.1038/sj.emboj.7600808 16148945
Heger K, Wickliffe KE, Ndoja A, Zhang J, Murthy A, Dugger DL, Maltzman A, de Sousa EMF, Hung J, Zeng Y, Verschueren E, Kirkpatrick DS, Vucic D, Lee WP, Roose-Girma M, Newman RJ, Warming S, Hsiao YC, Komuves LG, Webster JD, Newton K, Dixit VM OTULIN limits cell death and inflammation by deubiquitinating LUBAC Nature 2018 559 7712 120 124 10.1038/s41586-018-0256-2 29950720
Hua F, Hao W, Wang L, Li S Linear ubiquitination mediates EGFR-induced NF-kappaB pathway and tumor development Int J Mol Sci 2021 22 21 11875 10.3390/ijms222111875 34769306
Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J, Tokunaga F, Androulidaki A, Nakagawa T, Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B, Dikic I SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis Nature 2011 471 7340 637 641 10.1038/nature09814 21455181
Inn KS, Gack MU, Tokunaga F, Shi M, Wong LY, Iwai K, Jung JU Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction Mol Cell 2011 41 3 354 365 10.1016/j.molcel.2010.12.029 21292167
Jimbo K, Hattori A, Koide S, Ito T, Sasaki K, Iwai K, Nannya Y, Iwama A, Tojo A, Konuma T Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia Leukemia 2023 37 1 122 133 10.1038/s41375-022-01750-7 36352193
Jin Y, Peng Y, Xu J, Yuan Y, Yang N, Zhang Z, Xu L, Li L, Xiong Y, Sun D, Pan Y, Wu R, Fu J LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1alpha Oncogenesis 2024 13 1 6 10.1038/s41389-024-00508-3 38272870
Katsuya K, Oikawa D, Iio K, Obika S, Hori Y, Urashima T, Ayukawa K, Tokunaga F Small-molecule inhibitors of linear ubiquitin chain assembly complex (LUBAC), HOIPINs, suppress NF-kappa B signaling Biochem Biophys Res Commun 2019 509 3 700 706 10.1016/j.bbrc.2018.12.164 30611571
Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, Wauer T, Hospenthal MK, Gyrd-Hansen M, Krappmann D, Hofmann K, Komander D OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin Cell 2013 153 6 1312 1326 10.1016/j.cell.2013.05.014 23746843
Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, Sano S, Tokunaga F, Tanaka K, Iwai K A ubiquitin ligase complex assembles linear polyubiquitin chains EMBO J 2006 25 20 4877 4887 10.1038/sj.emboj.7601360 17006537
Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains EMBO Rep 2009 10 5 466 473 10.1038/embor.2009.55 19373254
Lafont E, Kantari-Mimoun C, Draber P, De Miguel D, Hartwig T, Reichert M, Kupka S, Shimizu Y, Taraborrelli L, Spit M, Sprick MR, Walczak H The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death EMBO J 2017 36 9 1147 1166 10.15252/embj.201695699 28258062
Lechtenberg BC, Rajput A, Sanishvili R, Dobaczewska MK, Ware CF, Mace PD, Riedl SJ Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation Nature 2016 529 7587 546 550 10.1038/nature16511 26789245
Lee IY, Lim JM, Cho H, Kim E, Kim Y, Oh HK, Yang WS, Roh KH, Park HW, Mo JS, Yoon JH, Song HK, Choi EJ MST1 negatively regulates TNFα-induced NF-κB signaling through modulating LUBAC activity Mol Cell 2019 73 6 1138 1149 10.1016/j.molcel.2019.01.022 30901564
Nakamura M, Tokunaga F, Sakata S, Iwai K Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex Biochem Biophys Res Commun 2006 351 2 340 347 10.1016/j.bbrc.2006.09.163 17069764
Nilsson J, Schoser B, Laforet P, Kalev O, Lindberg C, Romero NB, Davila Lopez M, Akman HO, Wahbi K, Iglseder S, Eggers C, Engel AG, Dimauro S, Oldfors A Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1 Ann Neurol 2013 74 6 914 919 10.1002/ana.23963 23798481
Niu J, Shi Y, Iwai K, Wu ZH LUBAC regulates NF-kappaB activation upon genotoxic stress by promoting linear ubiquitination of NEMO EMBO J 2011 30 18 3741 3753 10.1038/emboj.2011.264 21811235
Niu Z, Li X, Dong S, Gao J, Huang Q, Yang H, Qian H, Zhuo S, Zhuang T, Zhu J, Ding Y, Xu W The E3 ubiquitin ligase HOIP inhibits cancer cell apoptosis via modulating PTEN stability J Cancer 2021 12 21 6553 6562 10.7150/jca.61996 34659546
Oda H, Beck DB, Kuehn HS, Sampaio Moura N, Hoffmann P, Ibarra M, Stoddard J, Tsai WL, Gutierrez-Cruz G, Gadina M, Rosenzweig SD, Kastner DL, Notarangelo LD, Aksentijevich I Second case of HOIP deficiency expands clinical features and defines inflammatory transcriptome regulated by LUBAC Front Immunol 2019 10 479 10.3389/fimmu.2019.00479 30936877
Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, Martinez-Barbera JP, Silke J, Rodriguez TA, Walczak H HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death Cell Rep 2014 9 1 153 165 10.1016/j.celrep.2014.08.066 25284787
Rivkin E, Almeida SM, Ceccarelli DF, Juang YC, MacLean TA, Srikumar T, Huang H, Dunham WH, Fukumura R, Xie G, Gondo Y, Raught B, Gingras AC, Sicheri F, Cordes SP The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis Nature 2013 498 7454 318 324 10.1038/nature12296 23708998
Rodgers MA, Bowman JW, Fujita H, Orazio N, Shi M, Liang Q, Amatya R, Kelly TJ, Iwai K, Ting J, Jung JU The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation J Exp Med 2014 211 7 1333 1347 10.1084/jem.20132486 24958845
Schaeffer V, Akutsu M, Olma MH, Gomes LC, Kawasaki M, Dikic I Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling Mol Cell 2014 54 3 349 361 10.1016/j.molcel.2014.03.016 24726327
Seymour RE, Hasham MG, Cox GA, Shultz LD, Hogenesch H, Roopenian DC, Sundberg JP Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis Genes Immun 2007 8 5 416 421 10.1038/sj.gene.6364403 17538631
Smit JJ, van Dijk WJ, El Atmioui D, Merkx R, Ovaa H, Sixma TK Target specificity of the E3 ligase LUBAC for ubiquitin and NEMO relies on different minimal requirements J Biol Chem 2013 288 44 31728 31737 10.1074/jbc.M113.495846 24030825
Stieglitz B, Rana RR, Koliopoulos MG, Morris-Davies AC, Schaeffer V, Christodoulou E, Howell S, Brown NR, Dikic I, Rittinger K Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP Nature 2013 503 7476 422 426 10.1038/nature12638 24141947
Takiuchi T, Nakagawa T, Tamiya H, Fujita H, Sasaki Y, Saeki Y, Takeda H, Sawasaki T, Buchberger A, Kimura T, Iwai K Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN Genes Cells 2014 19 3 254 272 10.1111/gtc.12128 24461064
Tang Y, Joo D, Liu G, Tu H, You J, Jin J, Zhao X, Hung MC, Lin X Linear ubiquitination of cFLIP induced by LUBAC contributes to TNFalpha-induced apoptosis J Biol Chem 2018 293 52 20062 20072 10.1074/jbc.RA118.005449 30361438
Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S, Tanaka K, Nakano H, Iwai K SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex Nature 2011 471 7340 633 636 10.1038/nature09815 21455180
Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K, Kamei K, Ma A, Iwai K, Nureki O Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kappaB regulation EMBO J 2012 31 19 3856 3870 10.1038/emboj.2012.241 23032187
Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M, Akira S, Takao T, Tanaka K, Iwai K Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation Nat Cell Biol 2009 11 2 123 132 10.1038/ncb1821 19136968
van Well EM, Bader V, Patra M, Sanchez-Vicente A, Meschede J, Furthmann N, Schnack C, Blusch A, Longworth J, Petrasch-Parwez E, Mori K, Arzberger T, Trumbach D, Angersbach L, Showkat C, Sehr DA, Berlemann LA, Goldmann P, Clement AM, Behl C, Woerner AC, Saft C, Wurst W, Haass C, Ellrichmann G, Gold R, Dittmar G, Hipp MS, Hartl FU, Tatzelt J, Winklhofer KF A protein quality control pathway regulated by linear ubiquitination EMBO J 2019 38 9 e100730 10.15252/embj.2018100730 30886048
Venne AS, Kollipara L, Zahedi RP The next level of complexity: crosstalk of posttranslational modifications Proteomics 2014 14 4-5 513 524 10.1002/pmic.201300344 24339426
Verboom L, Hoste E, van Loo G OTULIN in NF-kappaB signaling, cell death, and disease Trends Immunol 2021 42 7 590 603 10.1016/j.it.2021.05.003 34074601
Wang W, Li M, Ponnusamy S, Chi Y, Xue J, Fahmy B, Fan M, Miranda-Carboni GA, Narayanan R, Wu J, Wu ZH ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/beta-catenin activation to enhance drug resistance in breast cancers Nat Commun 2020 11 1 3965 10.1038/s41467-020-17770-9 32770022
Wiborg O, Pedersen MS, Wind A, Berglund LE, Marcker KA, Vuust J The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences EMBO J 1985 4 3 755 759 10.1002/j.1460-2075.1985.tb03693.x 2988935
Wu M, Chang Y, Hu H, Mu R, Zhang Y, Qin X, Duan X, Li W, Tu H, Zhang W, Wang G, Han Q, Li A, Zhou T, Iwai K, Zhang X, Li H LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores Nat Commun 2019 10 1 273 10.1038/s41467-018-08043-7 30655516
Yang Y, Schmitz R, Mitala J, Whiting A, Xiao W, Ceribelli M, Wright GW, Zhao H, Yang Y, Xu W, Rosenwald A, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Wiestner A, Kruhlak MJ, Iwai K, Bernal F, Staudt LM Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms Cancer Discov 2014 4 4 480 493 10.1158/2159-8290.CD-13-0915 24491438
Yang YK, Yang C, Chan W, Wang Z, Deibel KE, Pomerantz JL Molecular determinants of scaffold-induced linear ubiquitinylation of B cell lymphoma/leukemia 10 (Bcl10) during T cell receptor and oncogenic caspase recruitment domain-containing protein 11 (CARD11) signaling J Biol Chem 2016 291 50 25921 25936 10.1074/jbc.M116.754028 27777308
Zhang H, Zhao X, Guo Y, Chen R, He J, Li L, Qiang Z, Yang Q, Liu X, Huang C, Lu R, Fang J, Cao Y, Huang J, Wang Y, Huang J, Chen GQ, Cheng J, Yu J Hypoxia regulates overall mRNA homeostasis by inducing Met (1)-linked linear ubiquitination of AGO2 in cancer cells Nat Commun 2021 12 1 5416 10.1038/s41467-021-25739-5 34518544
Zhang J, Clark K, Lawrence T, Peggie MW, Cohen P An unexpected twist to the activation of IKKbeta: TAK1 primes IKKbeta for activation by autophosphorylation Biochem J 2014 461 3 531 537 10.1042/BJ20140444 24911653
Zinngrebe J, Rieser E, Taraborrelli L, Peltzer N, Hartwig T, Ren HW, Kovacs I, Endres C, Draber P, Darding M, von Karstedt S, Lemke J, Dome B, Bergmann M, Ferguson BJ, Walczak H LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation J Exp Med 2016 213 12 2671 2689 10.1084/jem.20160041 27810922
Zuo Y, Feng Q, Jin L, Huang F, Miao Y, Liu J, Xu Y, Chen X, Zhang H, Guo T, Yuan Y, Zhang L, Wang J, Zheng H Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling Nat Commun 2020 11 1 1146 10.1038/s41467-020-14948-z 32123171
